Professor of Medicine, Brigham and Women's Hospital
Endocrinology
Dr. Gordon H. Williams, MD
|
|
Give Review
Gordon Williams works in the field of Endocrinology. He went to Harvard Medical School. Harvard Medical School is a top medical college. Harvard Medical School is ranked 1/12 in Research/PrimaryCare. He has 2 awards "Elected Member" and "Investigator Alumnus". Gordon Williams is a published doctor. He has 87 papers published. The most current publication "Statin Use and Adrenal Aldosterone Production in Hypertensive and Diabetic Subjects." He accepts Medicare payments and is registered with Medicare.gov.
Publications
- Statin Use and Adrenal Aldosterone Production in Hypertensive and Diabetic Subjects.
- Estrogen receptor inhibits mineralocorticoid receptor transcriptional regulatory function.
- Aldosterone dysregulation With aging predicts renal vascular function and cardiovascular risk.
- Effect of mineralocorticoid receptor antagonist on insulin resistance and endothelial function in obese subjects.
- Human interventions to characterize novel relationships between the renin-angiotensin-aldosterone system and parathyroid hormone.
- Statins and musculoskeletal adverse events.
- Long-term dietary sodium restriction increases adiponectin expression and ameliorates the proinflammatory adipokine profile in Obesity.
- Aldosterone's mechanism of action: roles of lysine-specific demethylase 1, caveolin and striatin.
- Predictors of plasma and urinary catecholamine levels in normotensive and hypertensive men and women.
- Lysine-specific demethylase-1 modifies the age effect on blood pressure sensitivity to dietary salt intake.
- Abnormal aldosterone physiology and cardiometabolic risk factors.
- Direct renin inhibition modulates insulin resistance in caveolin-1-deficient mice.
- Nonmodulation as the Mechanism for Salt Sensitivity of Blood Pressure in Individuals with Hypertension and Type 2 Diabetes Mellitus.
- Different Polymorphisms of the Mineralocorticoid Receptor Gene Are Associated With either Glucocorticoid or Mineralocorticoid Levels in Hypertension.
- Lysine-Specific Demethylase 1: An Epigenetic Regulator of Salt-Sensitive Hypertension.
- Altered Systemic Hemodynamic & Baroreflex Response to Angiotensin II in Postural Tachycardia Syndrome.
- Activation of the Mineralocorticoid Receptor Increases Striatin Levels.
- Replication and meta-analysis of the gene-environment interaction between body mass index and the interleukin-6 promoter polymorphism With higher insulin resistance.
- Histone Demethylase LSD1 Deficiency during High Salt Diet is Associated With Enhanced Vascular Contraction, Altered NO-cGMP Relaxation Pathway, and Hypertension.
- Dietary sodium intake regulates angiotensin II Type 1, mineralocorticoid receptor and associated signaling proteins in heart.
- Inflammation and hypertension: the interplay of interleukin-6, dietary sodium, and the renin-angiotensin system in humans.
- Exercise Training Versus Propranolol in the Treatment of the Postural Orthostatic Tachycardia Syndrome.
- Variants of the Caveolin-1 Gene: A Translational Investigation Linking Insulin Resistance and Hypertension.
- Mineralocorticoid receptor (MR) expression in human venous smooth muscle cells: A potential role for aldosterone signaling in vein graft arterialization.
- Renin gene polymorphism: its relationship to hypertension, renin levels and vascular responses.
- Cell Membrane-Associated Mineralocorticoid Receptors?: New Evidence.
- THE INFLUENCE OF BODY-MASS INDEX AND RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM ACTIVITY ON THE RELATIONSHIP BETWEEN 25-HYDROXYVITAMIN D AND ADIPONECTIN IN CAUCASIAN MEN.
- The association of the angiotensinogen gene with insulin sensitivity in humans: a tagging single nucleotide polymorphism and haploType approach.
- Low-salt diet increases insulin resistance in healthy subjects.
- The relationship between peroxisome proliferator-activated receptor-gamma and renin: a human genetics study.
- Menstrual cycle affects renal-Adrenal and hemodynamic responses during prolonged standing in the postural orthostatic tachycardia syndrome.
- Sensitivity of NOS-dependent vascular relaxation pathway to mineralocorticoid receptor blockade in caveolin-1-deficient mice.
- Aldosterone production and insulin resistance in healthy adults.
- Caveolin-1 ablation reduces the adverse cardiovascular effects of N-omega-nitro-L-arginine methyl ester and angiotensin II.
- Education for physician clinical researchers: should one size fit all?
- Correlation of glycyrrhetinic acid-like factors (kidney 11beta-HSD2-GALFs) With urinary free cortisol and plasma renin activity in essential hypertension.
- Mineralocorticoid receptor blockade reverses Obesity-related changes in expression of adiponectin, peroxisome proliferator-activated receptor-gamma, and proinflammator...
- A comparison of the aldosterone-blocking agents eplerenone and spironolactone.
- Effect of dietary sodium on vasoconstriction and eNOS-mediated vascular relaxation in caveolin-1-deficient mice.
- Effects of estradiol and the angiotensin II receptor blocker irbesartan on vascular function in postmenopausal women.
- Body mass index predicts aldosterone production in normotensive adults on a high-salt diet.
- Aldosterone: villain or protector?
- Response to Type 2 Deiodinase Thr92Ala Polymorphism Is Not Associated With Arterial Hypertension in Type 2 Diabetes Mellitus Patients.
- Urinary free cortisol: an intermediate phenoType and a potential genetic marker for a salt-resistant subset of essential hypertension.
- Ala92 Type 2 deiodinase allele increases risk for the development of hypertension.
- Insulin induces Renal vasodilation, increases plasma renin activity, and sensitizes the Renal vasculature to angiotensin receptor blockade in healthy subjects.
- Uric acid and the development of hypertension: the normative aging study.
- Mineralocorticoid receptor antagonist reduces renal injury in rodent models of types 1 and 2 Diabetes mellitus.
- Beta-2 adrenergic receptor diploType defines a subset of salt-sensitive hypertension.
- Familial aggregation of insulin resistance and cardiovascular risk factors in hypertension.
- Selective aldosterone blockade with eplerenone reduces albuminuria in patients with type 2 Diabetes.
- Cortisol circadian rhythm alterations in psychotic major depression.
- Effect of acute aldosterone administration on gene expression profile in the heart.
- Nonmodulation and essential hypertension.
- Aggregation of high-normal thyroid-stimulating hormone in hypertensive families.
- Bed rest effects on human calf hemodynamics and orthostatic intolerance: a model-based analysis.
- Sex differences in the genetic basis of morning serum cortisol levels: genome-wide screen identifies two novel loci specific to women.
- Cardiovascular benefits of aldosterone receptor antagonists: what about potassium?
- Simulated microgravity induces microvolt T wave alternans.
- Genetics of human hypertension.
- Aldosterone and heart failure: the rest of the story.
- Aldosterone biosynthesis, regulation, and classical mechanism of action.
- Sleep restriction does not affect orthostatic tolerance in the simulated microgravity environment.
- Uric acid and the state of the intraRenal renin-angiotensin system in humans.
- Mineralocorticoid receptor antagonists and hypertension: is there a rationale?
- Aldosterone--villain or bystander?
- Thyroid function and blood pressure homeostasis in euthyroid subjects.
- Efficacy of eplerenone versus enalapril as monotherapy in systemic hypertension.
- Plasma aldosterone concentration in the patient with Diabetes mellitus.
- Diurnal variation of aldosterone and plasma renin activity: timing relation to melatonin and cortisol and consistency after prolonged bed rest.
- Loss of sodium modulation of plasma kinins in human hypertension.
- Effects of simulated microgravity on closed-loop cardiovascular regulation and orthostatic intolerance: analysis by means of system identification.
- Genetic determinants of nonmodulating hypertension.
- Effects of eplerenone, enalapril, and eplerenone/enalapril in patients With essential hypertension and left ventricular hypertrophy: the 4E-left ventricular hypertroph...
- Acute angiotensin II increases plasma F2-isoprostanes in salt-replete human hypertensives.
- Symptoms and the distress they cause: comparison of an aldosterone antagonist and a Calcium channel blocking agent in patients with systolic hypertension.
- 50th anniversary of aldosterone.
- Glomerular hemodynamics and the renin-angiotensin system in patients with type 1 Diabetes mellitus.
- Rosiglitazone improves insulin sensitivity and lowers blood pressure in hypertensive patients.
- Renal perfusion in blacks: alterations caused by insuppressibility of intrarenal renin With salt.
- PAI-1 in human hypertension: relation to hypertensive groups.
- Angiotensinogen genotype affects renal and Adrenal responses to angiotensin II in essential hypertension.
- Loss-of-function polymorphism of the human kallikrein gene With reduced urinary kallikrein activity.
- Familial aggregation of low-renin hypertension.
- Low-renin hypertension, altered sodium homeostasis, and an alpha-adducin polymorphism.
- Cardiac damage prevention by eplerenone: comparison With low sodium diet or potassium loading.
Schools
Harvard Medical School
University Chicago Hosps Clins
Peter Bent Brigham Hospital
Conditions Treated
- AdRenal Incidentaloma
- AdRenal Insufficiency
- Adrenogenital Disorders
- Calcium Metabolism Disorders
- View All
Doctors Specialties
- Endocrinology
Accepted Insurances
- Aetna HMO
- Choice Plus POS II
- Blue Card PPO
- BlueConnect HMO
- Blue with Managed Care Behavioral Health HMO
- Preferred Blue PPO
- Cigna HMO
- Cigna PPO
- Great West Healthcare-Cigna PPO
- Open Access Plus
- Commercial Insurance Company
- First Health (Coventry Health Care) PPO
- Harvard Pilgrim Health Care PPO
- Humana
- Medicare MCR
- MultiPlan PPO
- PHCS Network PPO
- Tufts PPO
- Choice Plus POS
- Navigate HMO
- Navigate POS
- Options PPO
Awards
- Elected Member
- Investigator Alumnus
Education
-
Brigham and Women's Hospital -
University of Chicago -
Harvard Medical School
Hospital
-
Brigham and Women's Hospital
Drug Facts
| NPI NUMBER | 1477503993 | |
| NPPES Provider LastName | WILLIAMS | |
| NPPES Provider FirstName | GORDON | |
| NPPES Provider ZIPCode | 02115 | |
| NPPES Provider State | MA | |
| Specialty Description | Endocrinology | |
| Total Claim Count | 164.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1477503993 |
| Last Name Of The Provider | WILLIAMS |
| First Name Of The Provider | GORDON |
| View All |
Similar Doctors
|
|
Dr. Geoffrey A. Walford, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Isaac S. Kohane, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Christos S. Mantzoros, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Eyiuche N. Okeke, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. George L. King, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Rachael L. Fawcett, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Pouneh K. Fazeli, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Gordon J. Strewler, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ronald A. Arky, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Bradford B. Lowell, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Caroline M. Apovian, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Lisa Ceglia, MD
This Doctor is OpenDoctor Recommended.
|